Vegan Diet and Type 1 Diabetes: What a Small Trial Can and Cannot Show
A small dietary study in adults with type 1 diabetes is interesting, but it should...
Tzield for Recently Diagnosed Stage 3 Type 1 Diabetes: What Families Should Know
FDA granted accelerated approval for Tzield in children ages 8 to 17 recently diagnosed with...
TRUE METRIX Glucose Meter Safety Alert: What Users Should Check
TRUE METRIX safety alert guide covering E-5 error risk, affected systems, FDA Class I recall...
Tirzepatide Maintenance Study: What SURMOUNT-MAINTAIN Means
Plain-language SURMOUNT-MAINTAIN summary covering continued tirzepatide, dose reduction, weight regain, study limits, and patient questions...
The Unseen Epidemic: Unpacking Global Diabetes Statistics
The Unseen Epidemic: Unpacking Global Diabetes Statistics: evidence-based guidance reviewed against current NICE and ADA...
Stem Cell Research and Type 1 Diabetes: Hope, Limits, and Safety
Stem cell and islet research for type 1 diabetes is moving fast, but it is...
Semaglutide FLOW Kidney and Heart Findings: What Patients Should Know
A new FLOW analysis reports that semaglutide kidney and all-cause death benefits were consistent across...
Semaglutide and Bone Fracture Risk: What People With Type 2 Diabetes Should Know
An ENDO 2026 real-world study linked semaglutide with fewer bone fractures than several other weight-loss...
Review finds GLP-1 medicines may help some children with obesity or type 2 diabetes, but long-term safety data are still limited
A pediatric review found GLP-1 medicines may help selected children and teens with obesity or...